Cansense
1 known investors
Find your way into Cansense
Sign up to see every warm intro you have to Cansense
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cansense team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CanSense develops a non-invasive blood test for early detection of bowel (colorectal) cancer, using laser spectroscopy and AI-driven data analytics to identify cancer and pre-cancerous polyps from a single sample. The label-free liquid biopsy aims to reduce the need for colonoscopies in cancer diagnostics.
Investors · 1
Frequently asked questions
- What does Cansense do?
- CanSense develops a non-invasive blood test for early detection of bowel (colorectal) cancer, using laser spectroscopy and AI-driven data analytics to identify cancer and pre-cancerous polyps from a single sample. The label-free liquid biopsy aims to reduce the need for colonoscopies in cancer diagnostics.
- Who are Cansense's investors?
- Cansense's investors include Wales Technology Seed Fund II.